The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production

Arthritis and Rheumatism

Volumn 58, Issue 9, 2008, Pages 2786-2797

  Dave, Mandar ^a   Attur, Mukundan ^a   Palmer, Glyn ^a   Al Mussawir, Hayf E ^a   Kennish, Lauren ^a   Patel, Jyoti ^a   Abramson, Steven B ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; COLLAGENASE 3; CYCLOOXYGENASE 2; CYTOCHROME C; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; LEUKOTRIENE B4; LIPOCORTIN 5; MATRIX METALLOPROTEINASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEOGLYCAN; RESVERATROL; STROMELYSIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CATABOLISM; CELL ISOLATION; CHONDROPROTECTION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MEMBRANE DEPOLARIZATION; MITOCHONDRION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANNEXIN A5; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CARTILAGE; CHONDROCYTES; CYCLOOXYGENASE 2; CYTOCHROMES C; DINOPROSTONE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-1BETA; LEUKOTRIENE B4; MATRIX METALLOPROTEINASES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OSTEOARTHRITIS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES;

EID: 51849141393     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23799     Document Type: Article

References (51)

1. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets [review]. Arthritis Rheum 2001;44:1237-47.
2. Yasuhara R, Miyamoto Y, Akaike T, Akuta T, Nakamura M, Takami M, et al. Interleukin-1β induces death in chondrocyte-like ATDC5 cells through mitochondrial dysfunction and energy depletion in a reactive nitrogen and oxygen species-dependent manner. Biochem J 2005;389(Pt 2):315-23.
3. Terkeltaub R, Johnson K, Murphy A, Ghosh S. Invited review: the mitochondrion in osteoarthritis [review]. Mitochondrion 2002;1:301-19.
4. Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev 2007;39:443-55.
5. Yudoh K, Nguyen T, Nakamura H, Hongo-Masuko K, Kato T, Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005;7:R380-91.
6. Fulda S, Debatin KM. Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect Prev 2006;30:217-23.
7. Delmas D, Lancon A, Colin D, Jannin B, Latruffe N. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets 2006;7:423-42.
8. Sun AY, Simonyi A, Sun GY. The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 2002;32:314-8.
9. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493-506.
10. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006;127:1109-22.
11. Zhong M, Cheng GF, Wang WJ, Guo Y, Zhu XY, Zhang JT. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice. Phytomedicine 1999;6:79-84.
12. Jang DS, Kang BS, Ryu SY, Chang IM, Min KR, Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem Pharmacol 1999;57:705-12.
13. Subbaramaiah K, Michaluart P, Chung WJ, Tanabe T, Telang N, Dannenberg AJ. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann N Y Acad Sci 1999;889:214-23.
14. Moreno JJ. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J Pharmacol Exp Ther 2000;294:333-8.
15. Mutoh M, Takahashi M, Fukuda K, Matsushima-Hibiya Y, Mutoh H, Sugimura T, et al. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 2000;21:959-63.
16. Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 2005;16:533-40.
17. Anekonda TS. Resveratrol - a boon for treating Alzheimer's disease? Brain Res Rev 2006;52:316-26.
18. Elmali N, Esenkaya I, Harma A, Ertem K, Turkoz Y, Mizrak B. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res 2005;54:158-62.
19. Attur MG, Dave M, Cipolletta C, Kang P, Goldring MB, Patel IR, et al. Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor: potential for pharmacological intervention. J Biol Chem 2000;275:40307-15.
20. -ΔΔCT method. Methods 2001;25:402-8.
21. 2 production by nitric oxide in activated murine macrophages. J Immunol 1999;162:4191-7.
22. Thomas CM, Fuller CJ, Whittles CE, Sharif M. Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage 2006;15:27-34.
23. 4 in osteoarthritic chondrocytes: role of transforming growth factor β and eicosanoids. Arthritis Rheum 2004;50:3925-33.
24. Dingle JT. Catabolin - a cartilage catabolic factor from synovium. Clin Orthop Relat Res 1981;156:219-31.
25. Tyler JA. Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J 1985;227:869-78.
26. D'Lima D, Hermida J, Hashimoto S, Colwell C, Lotz M. Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. Arthritis Rheum 2006;54:1814-21.
27. Afanas'Ev IB. Mechanism of superoxide-mediated damage relevance to mitochondrial aging. Ann N Y Acad Sci 2004;1019:343-5.
28. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007;16:1246-52.
29. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004;(427 Suppl):S27-36.
30. Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis - an untreatable disease? [published erratum appears in Nat Rev Drug Discov 2005;4:543]. Nat Rev Drug Discov 2005;4:331-44.
31. Amin AR, Dave M, Attur M, Abramson SB. COX-2, NO, and cartilage damage and repair. Curr Rheumatol Rep 2000;2:447-53.
32. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998;273:21875-82.
33. Johnson JL, Maddipati KR. Paradoxical effects of resveratrol on the two prostaglandin H synthases. Prostaglandins Other Lipid Mediat 1998;56:131-43.
34. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-20.
35. Pelletier JP, Boileau C, Boily M, Brunet J, Mineau F, Geng C, et al. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res Ther 2005;7:R1091-102.
36. MacCarrone M, Lorenzon T, Guerrieri P, Agro AF. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 1999;265:27-34.
37. Pillinger MH, Dinsell V, Apsel B, Tolani SN, Marjanovic N, Chan ES, et al. Regulation of metalloproteinases and NF-κB activation in rabbit synovial fibroblasts via E prostaglandins and Erk: contrasting effects of nabumetone and 6MNA. Br J Pharmacol 2004;142:973-82.
38. Sadowski T, Steinmeyer J. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Osteoarthritis Cartilage 2001;9:407-15.
39. 2 exerts catabolic effects in OA cartilage: evidence for signaling via the EP4 receptor. J Immunol. In press.
40. Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS, et al. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC-δ signal transduction. Oncogene 2004;23:1845-53.
41. Kim HA, Blanco FJ. Cell death and apoptosis in osteoarthritic cartilage. Curr Drug Targets 2007;8:333-45.
42. Lopez-Armada MJ, Carames B, Martin MA, Cillero-Pastor B, Lires-Dean M, Fuentes-Boquete I, et al. Mitochondrial activity is modulated by TNFα and IL-1β in normal human chondrocyte cells. Osteoarthritis Cartilage 2006;14:1011-22.
43. Plin C, Tillement JP, Berdeaux A, Morin D. Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liver. Eur J Pharmacol 2005;528:162-8.
44. Csaki C, Keshishzadeh N, Fischer K, Shakibaei M. Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol 2008;75:677-87.
45. Shakibaei M, John T, Seifarth C, Mobasheri A. Resveratrol inhibits IL-1β-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann N Y Acad Sci 2007;1095:554-63.
46. 2 through cAMP-dependent pathway. Osteoarthritis Cartilage 2000;8:17-24.
47. 2 via the induction of cyclooxygenase-2. J Immunol 2000;165:3402-10.
48. 2 in human cancer cells: implication in apoptosis resistance. Exp Cell Res 2005;306:75-84.
49. 2 receptor activation. J Cell Physiol 2007;210:99-110.
50. 2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation. J Biol Chem 2003;278:12752-8.
51. Sexton E, Van Themsche C, Leblanc K, Parent S, Lemoine P, Asselin E. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer 2006;5:45.